Schedule 13G Filing by Reporting Persons for Monte Rosa Therapeutics, Inc.

The Schedule 13G filing reports the beneficial ownership of Common Stock of Monte Rosa Therapeutics, Inc. by several reporting persons, including Adam Goulburn, Zavain Dar, Nan Li, Dimension Management, L.P., Dimension Capital I GP, LLC, Dimension Management GP, LLC, and Dimension Capital I, L.P. The filing indicates that these reporting persons collectively own 7.7% of the outstanding shares, amounting to 4,757,563 shares. The shares are held directly by Dimension Capital I, with Dimension Management serving as the investment advisor. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement among the reporting persons.